Skip to main content

Find Clinical Trials

Home
Conditions
Lung Diseases, Obstructive

Clinical trial condition

Lung Diseases, Obstructive

Explore clinical trials studying Lung Diseases, Obstructive. Study availability and eligibility vary by location and protocol.

7,959 public trials 737 recruiting studies

Refine in advanced search Browse all conditions

Lung Diseases, Obstructive trial results

Completed

Efficacy, Safety, and Tolerability of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT01613326

Conditions: Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
Locations: Novartis Investigative Site Toronto, Ontario, Canada

Novartis Investigative Site Toronto, Ontario, Canada

Novartis Investigative Site Toronto, Ontario, Canada

Novartis Investigative Site Gatineau, Quebec, Canada

View all 77 locations

View Trial Details

Completed

A Pilot Study to Evaluate the ROX Anastomotic Coupler System in Patients With Chronic Obstructive Pulmonary Disease

NCT00992680

Conditions: Bronchial Diseases, Bronchitis, Bronchitis, Chronic, +12 more
Locations: Pulmonary Associates Phoenix, Arizona, United States

UCLA Medical Center Los Angeles, California, United States

Orlando Regional Health Care System Orlando, Florida, United States

Sarasota Memorial Hospital Sarasota, Florida, United States

View Trial Details

Completed

Leukotriene Polymorphisms and Montelukast Response - Ancillary to LoDo Trial

NCT00046644

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Not specified

View Trial Details

Completed

Development of the Partial Pressure of Carbon Dioxide During Exercise and at Night in Patients With Chronic Obstructive Pulmonary Disease (COPD) IV

NCT01696916

Conditions: Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
Locations: Klinikum Berchtesgadener Land Berchtesgaden, Germany

View Trial Details

Completed

Effects of an Oxymizer on Endurance Time in Patients With Chronic Lung Diseases

NCT01713413

Conditions: COPD, Chronic Disease, Disease Attributes, +8 more
Locations: Klinikum Berchtesgadener Land Berchtesgaden, Bavaria, Germany

View Trial Details

Completed

Effects of Rehabilitation on Muscle Fibre Composition and Capillaries in Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT01715337

Conditions: Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
Locations: Schön Klinik Berchtesgadener Land Schönau am Königssee, Germany

View Trial Details

Completed

Study in COPD (Chronic Obstructive Pulmonary Disease) Subjects to Investigate Safety, Tolerability, and Pharmacokinetics of Ciprofloxacin After Single Dose Inhalations of 50 mg and 75 mg Ciprofloxacin Inhalation Powder

NCT01168895

Conditions: Chronic Disease, Disease Attributes, Infection, +7 more
Locations: Großhansdorf, Schleswig-Holstein, Germany

View Trial Details

Completed

Effects of Salmeterol on Autonomic Nervous System

NCT01536587

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: GSK Investigational Site Göttingen, Lower Saxony, Germany

View Trial Details

Completed

Spiriva Observational Study Measuring Saint George's Respiratory Questionnaire (SGRQ) in Routine Medical Practice in Central & Eastern European Region

NCT01006135

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: Boehringer Ingelheim Investigational Site 1 Drniš, Croatia

Boehringer Ingelheim Investigational Site 2 Ivani? Grad-Zagreb, Croatia

Boehringer Ingelheim Investigational Site 3 Karlovac, Croatia

Boehringer Ingelheim Investigational Site 4 Knin, Croatia

View all 864 locations

View Trial Details

Completed

Observational Non-Interventional Study With Spiriva Respimat in COPD Patients

NCT00699699

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: Boehringer Ingelheim Investigational Site Aachen, Germany

Boehringer Ingelheim Investigational Site Amberg, Germany

Boehringer Ingelheim Investigational Site Auerbach, Germany

Boehringer Ingelheim Investigational Site 1 Augsburg, Germany

View all 188 locations

View Trial Details